Perrigo Company plc Equity Method Investments
Perrigo Company plc (PRGO) had Equity Method Investments of $23.20 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2026-08-05
- 2026-06-27: Equity Method Investments $23.20M.
- 2026-03-28: Equity Method Investments $23.50M.
- 2025-12-31: Equity Method Investments $23.40M.
- 2024-12-31: Equity Method Investments $57.30M.
| Period end | Equity Method Investments | Equity Method Investments as first filed |
|---|---|---|
| 2026-06-27 | $23.20M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $23.50M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $23.40M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $57.30M 10-K · filed 2026-02-26 | |
| 2014-09-27 | $0.00 8-K · filed 2014-11-20 | |
| 2014-06-28 | $0.00 8-K · filed 2014-11-20 | |
| 2014-03-29 | $60.60M 10-Q · filed 2014-05-07 | |
| 2013-12-28 | $69.00M 10-Q · filed 2014-02-06 | |
| 2013-06-29 | $0.00 10-K · filed 2014-08-14 | $4.40M 10-Q · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |